Cargando…

ROS, Klotho and mTOR in cardiorenal aging

Detalles Bibliográficos
Autores principales:	Daneshgar, Nastaran, Dai, Dao-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655185/ https://www.ncbi.nlm.nih.gov/pubmed/33125344 http://dx.doi.org/10.18632/aging.104209

Ejemplares similares

TOR Signaling Pathway in Cardiac Aging and Heart Failure
por: Daneshgar, Nastaran, et al.
Publicado: (2021)

The mTOR signaling pathway in cardiac aging
por: Dai, Dao-Fu, et al.
Publicado: (2023)

Age-related mTOR in gynaecological cancers
por: Bajwa, Preety, et al.
Publicado: (2017)

mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging
por: Das, Anindita, et al.
Publicado: (2017)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019)

mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging 2018
por: Das, Anindita, et al.
Publicado: (2019)

mTOR Signaling in Metabolism and Cancer
por: Huang, Shile
Publicado: (2020)

mTOR pathway activation in age-related retinal disease
por: Zhao, Chen, et al.
Publicado: (2011)

Klotho downregulation contributes to myocardial damage of cardiorenal syndrome in sepsis
por: Yan, Fei, et al.
Publicado: (2020)

Revisiting mTOR and Epithelial–Mesenchymal Transition
por: Herrerias, Mariana M., et al.
Publicado: (2020)

Exploiting the mTOR paradox for disease prevention
por: Iglesias-Bartolome, Ramiro, et al.
Publicado: (2012)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging
por: Das, Anindita, et al.
Publicado: (2023)

Grb2 Induces Cardiorenal Syndrome Type 3: Roles of IL-6, Cardiomyocyte Bioenergetics, and Akt/mTOR Pathway
por: Wang, Jin, et al.
Publicado: (2021)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

mTOR pathway in familial focal epilepsies
por: Ribierre, Théo, et al.
Publicado: (2016)

Inhibitors of mTOR in aging and cancer
por: Zhavoronkov, Alexander
Publicado: (2015)

microRNAs calibrate T cell responses by regulating mTOR
por: Merkenschlager, Matthias, et al.
Publicado: (2015)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

VEGF-mTOR signaling links obesity and endometrial cancer
por: Sahoo, Subhransu S., et al.
Publicado: (2018)

mTOR Signaling Network in Cell Biology and Human Disease
por: Yu, Jane J., et al.
Publicado: (2022)

mTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging
por: Węsierska-Gądek, Józefa
Publicado: (2010)

The Cardiorenal Syndrome
por: Rosner, Mitchell H., et al.
Publicado: (2011)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Targeting mTOR for Anti-Aging and Anti-Cancer Therapy
por: Fu, Wencheng, et al.
Publicado: (2023)

mTOR and Aging: An Old Fashioned Dress
por: Stallone, Giovanni, et al.
Publicado: (2019)

The role of mTOR in age-related diseases
por: Chrienova, Zofia, et al.
Publicado: (2021)

The mTOR–lysosome axis at the centre of ageing
por: Carosi, Julian M., et al.
Publicado: (2021)

STAT3 and mTOR: co-operating to drive HIF and angiogenesis
por: Dodd, Kayleigh M., et al.
Publicado: (2015)

mTOR and ROS regulation by anethole on adipogenic differentiation in human mesenchymal stem cells
por: Rhee, Yun-Hee, et al.
Publicado: (2018)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Recombinant α-Klotho Protein Alleviated Acute Cardiorenal Injury in a Mouse Model of Lipopolysaccharide-Induced Septic Cardiorenal Syndrome Type 5
por: Liu, Xi, et al.
Publicado: (2019)

The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer
por: Floc'h, Nicolas, et al.
Publicado: (2012)

PPARγ/mTOR signalling: striking the right balance in cartilage homeostasis
por: Dell'Accio, Francesco, et al.
Publicado: (2015)

An expression of concern on: Grb2 induces cardiorenal syndrome type 3: Roles of IL-6, cardiomyocyte bioenergetics, and Akt/mTOR pathway
Publicado: (2022)

Hyperglycemia-induced VEGF and ROS production in retinal cells is inhibited by the mTOR inhibitor, rapamycin
por: Kida, Teruyo, et al.
Publicado: (2021)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hfnvnl6nibmnov8c1h5a4nkimm